GSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine…
Read MoreGSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine…
Read MoreThe head of the World Health Organization made his strongest comments yet about the devastation…
Read MoreThe head of the World Health Organization made his strongest comments yet about the devastation…
Read MoreJapan has welcomed back a flood of tourists as COVID-related travel restrictions implemented more than…
Read MoreEconomies across the world face a constellation of risks that put the global financial system…
Read MoreMedicare’s annual enrollment period begins on Oct. 15 and lasts until Dec. 7, but beneficiaries…
Read MoreBoston health officials are concerned about elevated levels of the coronavirus in the city’s wastewater,…
Read MoreBoston health officials are concerned about elevated levels of the coronavirus in the city’s wastewater,…
Read MoreA large number of U.S. COVID deaths could be prevented if patients would take Paxlovid,…
Read MoreGSK PLC GSK, -0.10% said Monday that the U.S. Food and Drug Administration has approved…
Read More